Growth, Trends and Report Highlights

According to a new report Global Ventricular Assist Devices (VADs) Market, published by KBV research, The Global Ventricular Assist Devices (VADs) Market size is expected to reach $11.1 billion by 2024, rising at a market growth of 11.1% CAGR during the forecast period.

The North America market would dominate the Global Left Ventricular Assist Devices (LVADs) Market by Region 2024; growing at a CAGR of 10.5 % during the forecast period. The Europe market is expected to witness a CAGR of 11% during (2018 - 2024). Additionally, the Asia Pacific market is expected to witness a CAGR of 12.7% during (2018 - 2024).

The Implantable Ventricular Assist Devices market dominated the Global Ventricular Assist Devices Market by Design 2017, thereby, achieving a market value of $1183.4 million by 2024. The Transcutaneous Ventricular Assist Devices market is expected to witness a CAGR of 11.7% during (2018 - 2024).

The North America market dominated the Global Bridge-to-transplant (BTT) Therapy Ventricular Assist Devices Market by Region 2017, growing at a CAGR of 9.2 % during the forecast period. The Europe market is expected to witness a CAGR of 9.7% during (2018 - 2024). Additionally, the Asia Pacific market is expected to witness a CAGR of 11.4% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/ventricular-assist-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Berlin Heart GmbH, Cardiac Assist, Inc. ( LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed.

Global Ventricular Assist Devices (VADs) Market Segmentation

By Product

• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)

By Design

• Implantable Ventricular Assist Devices
• Transcutaneous Ventricular Assist Devices

By Application

• Bridge-to-transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-recovery (BTR) Therapy
• Bridge-to-candidacy (BTC) Therapy

 By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Berlin Heart GmbH,
• Cardiac Assist, Inc. ( LivaNova)
• HeartWare International, Inc.
• Jarvik Heart, Inc.
• Reliant Heart, Inc.
• Abbott
•  Sun Medical Technology Research Corp.
• Syncardia System, Inc.
• Thoratec Corporation
• Abiomed

Unique Offerings from KBV Research

• Exhaustive coverage  
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Ventricular Assist Devices Market

Europe Ventricular Assist Devices Market

Asia Pacific Ventricular Assist Devices Market

LAMEA Ventricular Assist Devices Market